Case Summary:

Our client, a postdoctoral fellow in the field of biochemistry from China, approached the North America Immigration Law Group to assist him in getting an EB-1A (Alien of Extraordinary Ability) visa. As per our protocols, we advised our client to send us a list of evidence that would prove the veracity of his credentials. After we received the package of evidence containing our client’s Ph.D. degree in biological sciences, his curriculum vitae, and the employment letter confirming his current position in the current organization, we decided to countersign the attorney-client relationship agreement and lead him to his EB1A success.

Our objective was to prepare a strong petition on behalf of our client as a qualified immigrant under the first preference employment immigration for Aliens of Extraordinary Ability, for which we detailed the following in his petition dossier:

It was noteworthy to mention the 448 citations his work acquired by other researchers in more than 30 countries, indicating the importance of his research around the world. In fact, a number of his publications have also been cited at a much higher rate than those of other researchers in the field, which also led us to specify the 23 peer-reviewed scientific articles he published in some of the most authoritative and influential journals in the field to date.

Additionally, we listed the outstanding 40 peer reviews our client conducted. As only the best researchers in the field are invited to judge the work of others, our client’s notable peer review record points to his high esteem in academia and his qualifying expertise as an authority in biochemistry.

Besides, we highlighted one of the most important elements of our client’s EB1A petition which is related to his research on analyzing the evolution of MBL genes and their clinical impact, and how it addresses the most pressing issues of our country, including the development of drugs and treatments for diseases and addressing antibiotic resistance.

We further added 5 recommendation letters signed by other well-recognized experts in the field, one of whom opinionated, “I consider him a standout scientist amongst his fellows, for he has shown uncommon innovation during his research… [Client] has earned every opportunity to continue to make groundbreaking achievements in topics that are of great interest to the biochemistry research community as a researcher in the United States.”

We are pleased that our hard work did not go in vain, and we were able to prove that our client is in the upper echelon of biochemists in the United States and he must continue contributing to the scientific discourse in the biochemistry community. Therefore, the USCIS granted him the EB1A approval. We sincerely thank him for choosing us and for upgrading his case to a premium processing service (a paid prospect offered by the USCIS that lets petitioners enjoy rapid adjudication), thus, his case received approval in just 1 month and 9 days. We wish him the best as he continues to advance in his desired field.